Structure's experimental obesity pill shows no signs of liver injury

What's Going On With Structure Therapeutics Stock On Wednesday?

Weight Loss Pill from Structure Therapeutics Trimmed the Most Pounds Yet. Is the Biotech a Takeover Candidate?

Structure Therapeutics Stock Explodes As Much-Awaited Experimental Oral Drug Trial Shows Weight Loss Of 16%

Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s

Structure Therapeutics CEO Says Compounding Threat Looms For Future Obesity Treatments